NL
DE
3 January 2017
Myrte Neijenhuis will use the Christine Mohrmann Stipendium to assess the impact of different treatments on quality of life in collaboration with the Mayo Clinic, Rochester, US. She will also use this Stipendium to obtain FDA-approval for the use of the PLD-Q as useful tool to measure quality of life in this population.
Recently Myrte Neijenhuis, theme Renal disorders received the Christine Mohrman Stipendium.
Myrte Neijenhuis showed that quality of life of patients with polycystic liver disease is significantly worse than the general population. To justify the use of surgical or medical therapies in this population, the impact on quality of life needs to be proven. She has developed and validated an instrument (the PLD-Q) to measure the quality of life in these patients.Myrte Neijenhuis will use the Christine Mohrmann Stipendium to assess the impact of different treatments on quality of life in collaboration with the Mayo Clinic, Rochester, US. She will also use this Stipendium to obtain FDA-approval for the use of the PLD-Q as useful tool to measure quality of life in this population.
Related news items
Joint research in regional hospitals New research projects from promotion fund
22 November 2022Four research projects have been honored in the promotion fund of the Radboudumc and four regional hospitals. The research projects, which are a collaboration between CWZ, Jeroen Bosch Hospital, Rijnstate, Sint Maartenskliniek and the Radboudumc will receive a contribution of 240,000 euros.
read more
Trained immunity’s role in kidney disease
17 November 2022Researcher(s) Jordi Ochando of the Icahn School of Medicine at Mount Sinai in New York and Raphaël Duivenvoorden of the Department of Nephrology at Radboudumc explain how trained immunity can have detrimental effects in kidney disease and transplantation.
read more